| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1026439887 |
| P356 | DOI | 10.1038/NATURE07021 |
| P2888 | exact match | https://scigraph.springernature.com/pub.10.1038/nature07021 |
| P932 | PMC publication ID | 2760130 |
| P698 | PubMed publication ID | 18469800 |
| P5875 | ResearchGate publication ID | 5381348 |
| P50 | author | David A. Hafler | Q25004567 |
| Vijay Kuchroo | Q87889159 | ||
| P2093 | author name string | Li Yang | |
| David E Anderson | |||
| Estelle Bettelli | |||
| Mohamed Oukka | |||
| Clare Baecher-Allan | |||
| William D Hastings | |||
| P2860 | cites work | IL-21 is produced by Th17 cells and drives IL-17 production in a STAT3-dependent manner | Q24644925 |
| Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells | Q27860460 | ||
| Transforming growth factor-beta induces development of the T(H)17 lineage | Q28237370 | ||
| The IL-23/Th(17) axis: therapeutic targets for autoimmune inflammation | Q28266133 | ||
| TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells | Q28296956 | ||
| T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma | Q28506783 | ||
| IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways | Q29614839 | ||
| Essential autocrine regulation by IL-21 in the generation of inflammatory T cells | Q29616147 | ||
| IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells | Q29616148 | ||
| Development, cytokine profile and function of human interleukin 17-producing helper T cells | Q29617131 | ||
| Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells | Q29618163 | ||
| TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology | Q34712326 | ||
| Optimal induction of T helper 17 cells in humans requires T cell receptor ligation in the context of Toll-like receptor-activated monocytes. | Q36089312 | ||
| T(H)-17 differentiation: of mice and men | Q80826320 | ||
| P433 | issue | 7202 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 350-352 | |
| P577 | publication date | 2008-05-11 | |
| P1433 | published in | Nature | Q180445 |
| P1476 | title | IL-21 and TGF-beta are required for differentiation of human T(H)17 cells | |
| P478 | volume | 454 |
| Q41538707 | 5-Fluorouracil targets thymidylate synthase in the selective suppression of TH17 cell differentiation |
| Q26823326 | A cytokine-centric view of the pathogenesis and treatment of autoimmune arthritis |
| Q36594388 | A gender-related action of IFNbeta-therapy was found in multiple sclerosis. |
| Q36379556 | A guanidine-rich regulatory oligodeoxynucleotide improves type-2 diabetes in obese mice by blocking T-cell differentiation |
| Q28299539 | A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity |
| Q37393022 | A mutation in the Nlrp3 gene causing inflammasome hyperactivation potentiates Th17 cell-dominant immune responses |
| Q34243351 | A novel subset of CD4(+) T(H)2 memory/effector cells that produce inflammatory IL-17 cytokine and promote the exacerbation of chronic allergic asthma |
| Q37435526 | A polymorphism within IL21R confers risk for systemic lupus erythematosus |
| Q41995656 | A restricted role for TYK2 catalytic activity in human cytokine responses revealed by novel TYK2-selective inhibitors |
| Q39029629 | A review on interleukins: The key manipulators in rheumatoid arthritis |
| Q37587746 | A role for TGFbeta signaling in the pathogenesis of psoriasis |
| Q36742227 | A rush to judgment on Th17 |
| Q34304146 | A simple theoretical framework for understanding heterogeneous differentiation of CD4+ T cells. |
| Q35953466 | ALAIN01--Alemtuzumab in autoimmune inflammatory neurodegeneration: mechanisms of action and neuroprotective potential. |
| Q45795416 | AZ17: a new bispecific drug targeting IL-6 and IL-23 with potential clinical use--improves psoriasis in a human xenograft transplantation model. |
| Q37137554 | Aberrant T helper 17 cells and related cytokines in bone marrow microenvironment of patients with acute myeloid leukemia |
| Q42164739 | Activated IL-1RI Signaling Pathway Induces Th17 Cell Differentiation via Interferon Regulatory Factor 4 Signaling in Patients with Relapsing-Remitting Multiple Sclerosis |
| Q34328201 | Activated human CD4+CD45RO+ memory T-cells indirectly inhibit NLRP3 inflammasome activation through downregulation of P2X7R signalling |
| Q35609357 | Activated human valvular interstitial cells sustain interleukin-17 production to recruit neutrophils in infective endocarditis |
| Q43519933 | Activation of memory Th17 cells by domain 4 pneumolysin in human nasopharynx-associated lymphoid tissue and its association with pneumococcal carriage. |
| Q42938656 | Activation of the aryl hydrocarbon receptor reveals distinct requirements for IL-22 and IL-17 production by human T helper cells |
| Q82081093 | Active immunization against IL-23p19 improves experimental arthritis |
| Q37257225 | Adoptive immunotherapy: good habits instilled at youth have long-term benefits. |
| Q26771957 | Advances in T Helper 17 Cell Biology: Pathogenic Role and Potential Therapy in Multiple Sclerosis |
| Q26800128 | Alemtuzumab in Multiple Sclerosis: Mechanism of Action and Beyond |
| Q41654435 | Altered balance between self-reactive T helper (Th)17 cells and Th10 cells and between full-length forkhead box protein 3 (FoxP3) and FoxP3 splice variants in Hashimoto's thyroiditis |
| Q42756718 | Amelioration of experimental autoimmune encephalomyelitis by β-elemene treatment is associated with Th17 and Treg cell balance |
| Q37609515 | An Ocular Protein Triad Can Classify Four Complex Retinal Diseases. |
| Q49276761 | Anti-interleukin and interleukin therapies for psoriasis: current evidence and clinical usefulness. |
| Q37436795 | Anti-retroviral therapy fails to restore the severe Th-17: Tc-17 imbalance observed in peripheral blood during simian immunodeficiency virus infection. |
| Q35108215 | Application of ChIP-Seq and related techniques to the study of immune function |
| Q37821982 | Are Th17 cells an appropriate new target in the treatment of rheumatoid arthritis? |
| Q37956520 | Are we ready to start studies of Th17 cell manipulation as a therapy for cancer? |
| Q42259485 | Association between the TGFB1 -509C/T and TGFBR2 -875A/G polymorphisms and gastric cancer: a case-control study |
| Q84604367 | Association of the -31C/T functional polymorphism in the interleukin-1beta gene with the intractability of Graves' disease and the proportion of T helper type 17 cells |
| Q33804224 | Attenuation of cGVHD by C5a/C5aR blockade is associated with increased frequency of Treg |
| Q34135558 | Averting inflammation by targeting the cytokine environment |
| Q46642844 | Balance of Treg vs. T-helper cells in the transition from symptomless to lesional psoriatic skin. |
| Q26740440 | Balancing Inflammation: The Link between Th17 and Regulatory T Cells |
| Q36377233 | Bat3 promotes T cell responses and autoimmunity by repressing Tim-3–mediated cell death and exhaustion. |
| Q92481869 | Bidirectional Cross-Talk between Biliary Epithelium and Th17 Cells Promotes Local Th17 Expansion and Bile Duct Proliferation in Biliary Liver Diseases |
| Q90365182 | Biological and clinical significance of T helper 17 cell plasticity |
| Q37729119 | Bisphenol A in combination with TNF-alpha selectively induces Th2 cell-promoting dendritic cells in vitro with an estrogen-like activity |
| Q35669245 | Blocking IL-21 signaling ameliorates xenogeneic GVHD induced by human lymphocytes |
| Q26852013 | Breaking tolerance to thyroid antigens: changing concepts in thyroid autoimmunity |
| Q34579613 | C5a receptor-deficient dendritic cells promote induction of Treg and Th17 cells |
| Q64093199 | CD28 Individual Signaling Up-regulates Human IL-17A Expression by Promoting the Recruitment of RelA/NF-κB and STAT3 Transcription Factors on the Proximal Promoter |
| Q35061140 | CD39+ regulatory T cells suppress generation and differentiation of Th17 cells in human malignant pleural effusion via a LAP-dependent mechanism |
| Q34813153 | CD4 T cells: fates, functions, and faults |
| Q91011142 | CD70 defines a subset of proinflammatory and CNS-pathogenic TH1/TH17 lymphocytes and is overexpressed in multiple sclerosis |
| Q91292380 | Cajanonic acid A regulates the ratio of Th17/Treg via inhibition of expression of IL-6 and TGF-β in insulin-resistant HepG2 cells |
| Q47390109 | Cancer cells induce interleukin-22 production from memory CD4+ T cells via interleukin-1 to promote tumor growth |
| Q37046916 | Cardiac myosin-Th17 responses promote heart failure in human myocarditis |
| Q92697835 | Caspase-11-dependent IL-1α release boosts Th17 immunity against Paracoccidioides brasiliensis |
| Q38098176 | Cell-Mediated Immunity in Elite Controllers Naturally Controlling HIV Viral Load. |
| Q33831578 | Cellular Stress in the Context of an Inflammatory Environment Supports TGF-β-Independent T Helper-17 Differentiation |
| Q39241774 | Cellular and Molecular Dynamics of Th17 Differentiation and its Developmental Plasticity in the Intestinal Immune Response |
| Q34096571 | Central nervous system (CNS)-resident natural killer cells suppress Th17 responses and CNS autoimmune pathology. |
| Q37154827 | Clitocybe nuda Activates Dendritic Cells and Acts as a DNA Vaccine Adjuvant. |
| Q35069894 | Co-culture of human bronchial fibroblasts and CD4+ T cells increases Th17 cytokine signature |
| Q45221842 | Combined analysis of cytokine gene polymorphism and the level of expression with allograft function in kidney transplant recipients |
| Q42500332 | Comparison of interferon-γ-, interleukin (IL)-17- and IL-22-expressing CD4 T cells, IL-22-expressing granulocytes and proinflammatory cytokines during latent and active tuberculosis infection. |
| Q35160651 | Complement component C5a promotes expression of IL-22 and IL-17 from human T cells and its implication in age-related macular degeneration |
| Q34201256 | Control of TH17 cells occurs in the small intestine. |
| Q35114894 | Converging pathways lead to overproduction of IL-17 in the absence of vitamin D signaling |
| Q37316232 | Correlation between the frequency of Th17 cell and the expression of microRNA-206 in patients with dermatomyositis. |
| Q37250727 | Critical regulation of early Th17 cell differentiation by interleukin-1 signaling |
| Q56573336 | Crucial role of interleukin-7 in T helper type 17 survival and expansion in autoimmune disease |
| Q36977772 | Current and potential immune therapies and vaccines in the management of psoriasis |
| Q35606563 | Current status of the immunomodulation and immunomediated therapeutic strategies for multiple sclerosis |
| Q34249937 | Cytokine requirements for the differentiation and expansion of IL-17A- and IL-22-producing human Vgamma2Vdelta2 T cells. |
| Q34309180 | Decreased cellular IL-23 but not IL-17 production in children with autism spectrum disorders |
| Q46175551 | Dectin-1 directs T helper cell differentiation by controlling noncanonical NF-kappaB activation through Raf-1 and Syk. |
| Q38961438 | Deficiency of the immunostimulatory cytokine IL-21 promotes intestinal neoplasia via dysregulation of the Th1/Th17 axis. |
| Q38110935 | Dendritic cells in myelodysplastic syndromes: from pathogenesis to immunotherapy. |
| Q34981514 | Detection for pathway effect contributing to disease in systems epidemiology with a case-control design. |
| Q40041978 | Development of Inflammatory Bowel Disease Is Linked to a Longitudinal Restructuring of the Gut Metagenome in Mice |
| Q37256107 | Development of a murine mycobacterial growth inhibition assay for evaluating vaccines against Mycobacterium tuberculosis |
| Q37682642 | Development, regulation and functional capacities of Th17 cells |
| Q42025675 | Developmental regulation of Th17-cell capacity in human neonates |
| Q43254667 | Differential effect of cyclosporine and mycophenolic acid on the human regulatory T cells and TH-17 cells balance |
| Q34468545 | Differential mucosal expression of Th17-related genes between the inflamed colon and ileum of patients with inflammatory bowel disease |
| Q48150434 | Disease-Specific Effects of Matrix and Growth Factors on Adhesion and Migration of Rheumatoid Synovial Fibroblasts |
| Q54979857 | Distinct In Vitro T-Helper 17 Differentiation Capacity of Peripheral Naive T Cells in Rheumatoid and Psoriatic Arthritis. |
| Q45914518 | Distribution and functional plasticity of peripheral blood Th(c)17 and Th(c)1 in rheumatoid arthritis. |
| Q91646619 | Divergent Effect of Tacalcitol (PRI-2191) on Th17 Cells in 4T1 Tumor Bearing Young and Old Ovariectomized Mice |
| Q27010199 | Diversity of IL-17-producing T lymphocytes |
| Q38909319 | Downregulating galectin-3 inhibits proinflammatory cytokine production by human monocyte-derived dendritic cells via RNA interference |
| Q35928330 | Dual Role of GM-CSF as a Pro-Inflammatory and a Regulatory Cytokine: Implications for Immune Therapy. |
| Q39338915 | Dynamic Long-Range Chromatin Interaction Controls Expression of IL-21 in CD4+ T Cells. |
| Q33923351 | Dysregulated balance of Th17 and Th1 cells in systemic lupus erythematosus |
| Q37660688 | Dysregulation of mucosal immune response in pathogenesis of inflammatory bowel disease |
| Q92072023 | ERα Signaling Increased IL-17A Production in Th17 Cells by Upregulating IL-23R Expression, Mitochondrial Respiration, and Proliferation |
| Q53100157 | ERβ in CD4+ T Cells Is Crucial for Ligand-Mediated Suppression of Central Nervous System Autoimmunity. |
| Q28077990 | Ectopic Tertiary Lymphoid Tissue in Inflammatory Bowel Disease: Protective or Provocateur? |
| Q47808360 | Effect of aging on sputum inflammation and asthma control |
| Q34754302 | Effector CD4+ T cells, the cytokines they generate, and GVHD: something old and something new. |
| Q35084618 | Effector and regulatory T-cell subsets in autoimmunity and tissue inflammation |
| Q43657474 | Elevated Th17 cells accompanied by decreased regulatory T cells and cytokine environment in infants with biliary atresia |
| Q34950622 | Elevated proinflammatory cytokine production by a skewed T cell compartment requires monocytes and promotes inflammation in type 2 diabetes. |
| Q37003552 | Elevated serum and synovial fluid levels of interleukin-34 in rheumatoid arthritis: possible association with disease progression via interleukin-17 production |
| Q33955912 | Emerging role of IL-17 in atherosclerosis |
| Q38931950 | Enhanced Schwann cell attachment and alignment using one-pot "dual click" GRGDS and YIGSR derivatized nanofibers. |
| Q34195216 | Enhanced suppressor function of TIM-3+ FoxP3+ regulatory T cells |
| Q91670951 | Epigenetic Regulation in the Pathogenesis of Sjögren Syndrome and Rheumatoid Arthritis |
| Q93216342 | Ethanol consumption inhibits TFH cell responses and the development of autoimmune arthritis |
| Q53235460 | Evaluation of Immune Profiles and MicroRNA Expression Profiles in Peripheral Blood Mononuclear Cells of Long-Term Stable Liver Transplant Recipients and Recipients With Acute Rejection Episodes. |
| Q33687315 | Evidence for altered activity of the IL-6 pathway in chronic rhinosinusitis with nasal polyps |
| Q37316594 | Evidence that cytokines play a role in rheumatoid arthritis |
| Q42758695 | Exogenous IL-2 Induces FoxP3+ Th17 Cells In Vivo in Melanoma Patients |
| Q34892862 | Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys |
| Q84723547 | Experimentally induced psoriatic lesion associates with interleukin (IL)-6 in mast cells and appearance of dermal cells expressing IL-33 and IL-6 receptor |
| Q49391026 | Expression of Th17/Treg related molecules in gastric cancer tissues. |
| Q37403761 | Expression of tyrosine hydroxylase in CD4+ T cells contributes to alleviation of Th17/Treg imbalance in collagen-induced arthritis |
| Q34360200 | Expression of αvβ8 integrin on dendritic cells regulates Th17 cell development and experimental autoimmune encephalomyelitis in mice |
| Q42765133 | Extracellular matrix-associated cytokines regulate CD4+ effector T-cell responses in the human intestinal mucosa. |
| Q37446166 | FOXP3 and the regulation of Treg/Th17 differentiation |
| Q56899642 | FOXP3+ regulatory T cells and T helper 1, T helper 2, and T helper 17 cells in human early pregnancy decidua |
| Q91810029 | Fibrogenesis in Chronic DSS Colitis is Not Influenced by Neutralisation of Regulatory T Cells, of Major T Helper Cytokines or Absence of IL-13 |
| Q35019514 | Fine-mapping and transethnic genotyping establish IL2/IL21 genetic association with lupus and localize this genetic effect to IL21 |
| Q35242659 | Follicular helper T cell signature in type 1 diabetes |
| Q84307121 | Foxp3+ regulatory T cells of psoriasis patients easily differentiate into IL-17A-producing cells and are found in lesional skin |
| Q54453217 | Foxp3+ regulatory T cells, Th17 effector cells, and cytokine environment in inflammatory bowel disease. |
| Q39018591 | Foxp3, Regulatory T Cell, and Autoimmune Diseases |
| Q37374943 | From interleukin-23 to T-helper 17 cells: human T-helper cell differentiation revisited |
| Q38138105 | Functional plasticity of Th17 cells: implications in gastrointestinal tract function. |
| Q37850400 | Functional relevance of T helper 17 (Th17) cells and the IL-17 cytokine family in inflammatory bowel disease |
| Q37944472 | Future perspectives: should Th17 cells be considered as a possible therapeutic target in acute myeloid leukemia patients receiving allogeneic stem cell transplantation? |
| Q34999304 | Gene expression profile of peripheral blood monocytes: a step towards the molecular diagnosis of celiac disease? |
| Q34843832 | Generation and regulation of human CD4+ IL-17-producing T cells in ovarian cancer |
| Q38193824 | Genetic defects and the role of helper T-cells in the pathogenesis of common variable immunodeficiency |
| Q30352676 | Genetic variants in IL1A and IL1B contribute to the susceptibility to 2009 pandemic H1N1 influenza A virus. |
| Q38726782 | Genetics of autoimmune diseases: perspectives from genome-wide association studies |
| Q24655629 | Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4+ T cells |
| Q35075106 | Glycogen synthase kinase-3 is an early determinant in the differentiation of pathogenic Th17 cells |
| Q33738131 | Growth factors as treatment for inflammatory bowel disease: a concise review of the evidence toward their potential clinical utility |
| Q88092012 | Haplotype analysis on chromosome 6p of tumor necrosis factor alpha, vascular endothelial growth factor A, and interleukin-17F alleles associated with corneal transplant rejection |
| Q38202009 | Helper T-cell differentiation in graft-versus-host disease after allogeneic hematopoietic stem cell transplantation |
| Q34795426 | Hepatitis B virus induces IL-23 production in antigen presenting cells and causes liver damage via the IL-23/IL-17 axis |
| Q37578374 | Heterogeneity of CD4+ memory T cells: functional modules for tailored immunity |
| Q37669449 | Heterogeneity of human effector CD4+ T cells. |
| Q36270103 | Higher efficacy of anti-IL-6/IL-21 combination therapy compared to monotherapy in the induction phase of Th17-driven experimental arthritis |
| Q37873072 | How do immune cells overcome the blood-brain barrier in multiple sclerosis? |
| Q33800947 | Human IL-6RhiTIGIT- CD4+CD127lowCD25+ T cells display potent in vitro suppressive capacity and a distinct Th17 profile. |
| Q34320455 | Human RORγt+ TH17 cells preferentially differentiate from naive FOXP3+Treg in the presence of lineage-specific polarizing factors |
| Q51960210 | Human TSLP and TLR3 ligands promote differentiation of Th17 cells with a central memory phenotype under Th2-polarizing conditions. |
| Q51770932 | Human Th17 cells: are they different from murine Th17 cells? |
| Q38040742 | Human Th17 subsets |
| Q30499055 | Human mucosal in vivo transcriptome responses to three lactobacilli indicate how probiotics may modulate human cellular pathways |
| Q53298325 | Human umbilical cord derived mesenchymal stem cells promote interleukin-17 production from human peripheral blood mononuclear cells of healthy donors and systemic lupus erythematosus patients. |
| Q89986135 | Human inborn errors of immunity underlying superficial or invasive candidiasis |
| Q37727813 | IL-17 in systemic lupus erythematosus |
| Q33610883 | IL-17 induces monocyte migration in rheumatoid arthritis |
| Q38111443 | IL-17 targeted therapies for psoriasis |
| Q26996213 | IL-17+Foxp3+ T cells: an intermediate differentiation stage between Th17 cells and regulatory T cells |
| Q37858344 | IL-17-expressing cells as a potential therapeutic target for treatment of immunological disorders |
| Q33807584 | IL-17-mediated monocyte migration occurs partially through CC chemokine ligand 2/monocyte chemoattractant protein-1 induction |
| Q37838092 | IL-17-producing T cells in lupus nephritis |
| Q37176541 | IL-17-producing human peripheral regulatory T cells retain suppressive function |
| Q35853686 | IL-17/IL-10 double-producing T cells: new link between infections, immunosuppression and acute myeloid leukemia |
| Q37983096 | IL-17/IL-17 receptor system in autoimmune disease: mechanisms and therapeutic potential |
| Q41691958 | IL-21 Modulates Activation of NKT Cells in Patients with Stage IV Malignant Melanoma |
| Q34988311 | IL-21 drives secondary autoimmunity in patients with multiple sclerosis, following therapeutic lymphocyte depletion with alemtuzumab (Campath-1H) |
| Q35153018 | IL-21 production by CD4+ effector T cells and frequency of circulating follicular helper T cells are increased in type 1 diabetes patients |
| Q36084270 | IL-21 promotes lupus-like disease in chronic graft-versus-host disease through both CD4 T cell- and B cell-intrinsic mechanisms |
| Q37328260 | IL-22 and inflammation: leukin' through a glass onion |
| Q38081171 | IL-22, not simply a Th17 cytokine |
| Q50532113 | IL-23 and IL-1β Drive Human Th17 Cell Differentiation and Metabolic Reprogramming in Absence of CD28 Costimulation. |
| Q34440569 | IL-26 is overexpressed in rheumatoid arthritis and induces proinflammatory cytokine production and Th17 cell generation |
| Q33998909 | IL-27 is a key regulator of IL-10 and IL-17 production by human CD4+ T cells |
| Q33990291 | IL-6 signaling in psoriasis prevents immune suppression by regulatory T cells |
| Q48275402 | IL17A and IL23R gene polymorphisms affect the clinical features and prognosis of patients with multiple myeloma. |
| Q34062484 | IRF4 and its regulators: evolving insights into the pathogenesis of inflammatory arthritis? |
| Q24309586 | Il-21 enhances NK cell activation and cytolytic activity and induces Th17 cell differentiation in inflammatory bowel disease |
| Q53377409 | Imbalance Between Th17 Cells and Regulatory T Cells During Monophasic Experimental Autoimmune Uveitis. |
| Q42283750 | Imbalance of interleukin-17-producing CD4 T cells/regulatory T cells axis occurs in remission stage of patients with hepatitis B virus-related acute-on-chronic liver failure |
| Q31133324 | Imbalanced frequencies of Th17 and Treg cells in acute coronary syndromes are mediated by IL-6-STAT3 signaling |
| Q27015533 | Immune Components of Liver Damage Associated with Connective Tissue Diseases |
| Q38020961 | Immune checkpoints in central nervous system autoimmunity. |
| Q36745793 | Immune regulation in chronically transfused allo-antibody responder and nonresponder patients with sickle cell disease and β-thalassemia major |
| Q37317215 | Immune regulation of bone loss by Th17 cells. |
| Q38122647 | Immune system: a double-edged sword in cancer |
| Q42369863 | Immunity and Fibrogenesis: The Role of Th17/IL-17 Axis in HBV and HCV-induced Chronic Hepatitis and Progression to Cirrhosis. |
| Q36280862 | Immunologic and MRI markers of the therapeutic effect of IFN-β-1a in relapsing-remitting MS. |
| Q38008077 | Immunology mini-review: the basics of T(H)17 and interleukin-6 in transplantation |
| Q64102215 | Immunopathogenesis of Behcet's Disease |
| Q37842335 | Immunotherapeutic restoration in HIV-infected individuals |
| Q38091675 | Immunotherapy for the management of advanced melanoma: the next steps |
| Q26829264 | Immunovirological parameters and cytokines in HIV infection |
| Q35840846 | Impact of interleukin-21 in the pathogenesis of primary Sjögren's syndrome: increased serum levels of interleukin-21 and its expression in the labial salivary glands |
| Q35626699 | Impaired Th17 polarization of phenotypically naive CD4(+) T-cells during chronic HIV-1 infection and potential restoration with early ART |
| Q37258251 | In vivo action of IL-27: reciprocal regulation of Th17 and Treg cells in collagen-induced arthritis |
| Q36864299 | Increased Th17 cells in the tumor microenvironment is mediated by IL-23 via tumor-secreted prostaglandin E2. |
| Q42241131 | Increased circulating Th17 cell populations and elevated CSF osteopontin and IL-17 concentrations in patients with Guillain-Barré syndrome |
| Q37736855 | Increased circulatory levels of fractalkine (CX3CL1) are associated with inflammatory chemokines and cytokines in individuals with type-2 diabetes |
| Q84527284 | Increased frequencies of T helper type 17 cells in the peripheral blood of patients with acute myeloid leukaemia |
| Q44443284 | Increased frequencies of T helper type 17 cells in tuberculous pleural effusion |
| Q34614005 | Increased interleukin-23 receptor(+) T cells in peripheral blood mononuclear cells of patients with systemic lupus erythematosus |
| Q54288856 | Increased peripheral RORα and RORγt mRNA expression is associated with acute-on-chronic hepatitis B liver failure. |
| Q82663765 | Increased plasma levels of IL-21 and IL-23 in spondyloarthritis are not associated with clinical and MRI findings |
| Q44779348 | Increased prevalence of T(H)17 cells in the peripheral blood of patients with head and neck squamous cell carcinoma |
| Q44127552 | Increased prevalence of circulating novel IL-17 secreting Foxp3 expressing CD4+ T cells and defective suppressive function of circulating Foxp3+ regulatory cells support plasticity between Th17 and regulatory T cells in inflammatory bowel disease pa |
| Q54354343 | Increased prevalence of interleukin-17-producing CD4(+) tumor infiltrating lymphocytes in human oral squamous cell carcinoma. |
| Q34981029 | Increased systemic Th17 cytokines are associated with diastolic dysfunction in children and adolescents with diabetic ketoacidosis |
| Q33723950 | Induction and activation of human Th17 by targeting antigens to dendritic cells via dectin-1. |
| Q37194494 | Induction and effector functions of T(H)17 cells. |
| Q33778264 | Induction of TGF-beta1 and TGF-beta1-dependent predominant Th17 differentiation by group A streptococcal infection |
| Q51052754 | Induction of autoimmune diabetes in non-obese diabetic mice requires interleukin-21-dependent activation of autoreactive CD8⁺ T cells. |
| Q37311131 | Induction, function and regulation of IL-17-producing T cells |
| Q38017873 | Inflammatory bowel disease and pregnancy: overlapping pathways |
| Q26823647 | Inflammatory cytokines in systemic lupus erythematosus |
| Q34725846 | Infliximab therapy impacts the peripheral immune system of immunomodulator and corticosteroid naïve patients with Crohn's disease |
| Q35923173 | Inhalation of sulfur mustard causes long-term T cell-dependent inflammation: possible role of Th17 cells in chronic lung pathology |
| Q42561198 | Interaction among activated lymphocytes and mesenchymal cells through podoplanin is critical for a high IL-17 secretion |
| Q36652900 | Interactions among the transcription factors Runx1, RORgammat and Foxp3 regulate the differentiation of interleukin 17-producing T cells |
| Q37019593 | Interleukin (IL)-1 promotes allogeneic T cell intimal infiltration and IL-17 production in a model of human artery rejection. |
| Q52728029 | Interleukin 17 and peripheral IL-17-expressing T cells are negatively correlated with the overall survival of head and neck cancer patients. |
| Q58411438 | Interleukin-17 and interleukin-23: importance in the pathogenesis of lung impairment in patients with systemic sclerosis |
| Q37552021 | Interleukin-17 and systemic lupus erythematosus: current concepts |
| Q85068847 | Interleukin-17 exacerbates hepatic steatosis and inflammation in non-alcoholic fatty liver disease |
| Q46490236 | Interleukin-17-producing cell infiltration in the breast cancer tumour microenvironment is a poor prognostic factor. |
| Q37812288 | Interleukin-21 as a potential therapeutic target for systemic lupus erythematosus |
| Q36335882 | Interleukin-21 combined with ART reduces inflammation and viral reservoir in SIV-infected macaques |
| Q35375495 | Interleukin-21 gene polymorphisms and chronic hepatitis B infection in a Chinese population |
| Q42218255 | Interleukin-21 receptor deficiency increases the initial toll-like receptor 2 response but protects against joint pathology by reducing Th1 and Th17 cells during streptococcal cell wall arthritis |
| Q47342427 | Interleukin-21 receptor signalling is not critically required for imiquimod-induced psoriasiform dermatitis in mice. |
| Q37777114 | Interleukin-21 triggers effector cell responses in the gut |
| Q34388287 | Interleukin-21: a multifunctional regulator of immunity to infections |
| Q34002864 | Interleukin-21: a new mediator of inflammation in systemic lupus erythematosus |
| Q64994747 | Interleukin-22 receptor 1 is expressed in multinucleated giant cells: A study on intestinal tuberculosis and Crohn's disease. |
| Q37404716 | Interleukin-23/Th17 pathways and inflammatory bowel disease |
| Q37171985 | Interplay between Matrix Metalloproteinase-9, Matrix Metalloproteinase-2, and Interleukins in Multiple Sclerosis Patients |
| Q37276852 | Interplay between effector Th17 and regulatory T cells |
| Q87025205 | Involvement of IL-23 in enteropathic arthritis patients with inflammatory bowel disease: preliminary results |
| Q41200516 | Involvement of interleukin-21 in the pathophysiology of aplastic anemia |
| Q42094104 | Involvement of the IL-23/IL-17 axis and the Th17/Treg balance in the pathogenesis and control of autoimmune arthritis |
| Q39277348 | Is TGFβ as an anti-inflammatory cytokine required for differentiation of inflammatory TH17 cells? |
| Q89725150 | JQ1, a bromodomain inhibitor, suppresses Th17 effectors by blocking p300-mediated acetylation of RORγt |
| Q37688137 | Joint involvement in inflammatory bowel disease: managing inflammation outside the digestive system |
| Q31133829 | LDL cholesterol modulates human CD34+ HSPCs through effects on proliferation and the IL-17 G-CSF axis |
| Q35976768 | Leprosy Reactions Show Increased Th17 Cell Activity and Reduced FOXP3+ Tregs with Concomitant Decrease in TGF-β and Increase in IL-6 |
| Q34115001 | Ligand regulation of retinoic acid receptor-related orphan receptors: implications for development of novel therapeutics |
| Q39338146 | Low-strength T-cell activation promotes Th17 responses. |
| Q36110782 | Lymphocytic, cytokine and transcriptomic profiles in peripheral blood of dogs with atopic dermatitis |
| Q26796071 | Maintenance of Immune Homeostasis through ILC/T Cell Interactions |
| Q28238414 | Mast cells and neutrophils release IL-17 through extracellular trap formation in psoriasis |
| Q38543279 | Mechanism of neuroinflammation: enhanced cytotoxicity and IL-17 production via CD46 binding |
| Q38053867 | Mechanisms underlying lineage commitment and plasticity of human γδ T cells |
| Q37117838 | MicroRNA-17 Modulates Regulatory T Cell Function by Targeting Co-regulators of the Foxp3 Transcription Factor |
| Q24619604 | Molecular pathway profiling of T lymphocyte signal transduction pathways; Th1 and Th2 genomic fingerprints are defined by TCR and CD28-mediated signaling |
| Q50857085 | Monocyte-derived dendritic cells from Crohn's disease patients exhibit decreased ability to activate T helper type 17 responses in memory cells. |
| Q37405753 | Monocytes from patients with type 1 diabetes spontaneously secrete proinflammatory cytokines inducing Th17 cells |
| Q37698474 | Monomeric Immunoglobulin A from Plasma Inhibits Human Th17 Responses In Vitro Independent of FcαRI and DC-SIGN. |
| Q33728334 | More stories on Th17 cells |
| Q36339119 | Mouse CD11b+Gr-1+ myeloid cells can promote Th17 cell differentiation and experimental autoimmune encephalomyelitis |
| Q27011014 | Multiple sclerosis: the role of cytokines in pathogenesis and in therapies |
| Q91374811 | Murine models of psoriasis and its applications in drug development |
| Q36742242 | Mutations in STAT3 and IL12RB1 impair the development of human IL-17-producing T cells |
| Q37921386 | Myofibroblast differentiation and survival in fibrotic disease |
| Q36694466 | NK cells inhibit T-bet-deficient, autoreactive Th17 cells |
| Q53402655 | Neuroimmunologic and Neurotrophic Interactions in Autism Spectrum Disorders: Relationship to Neuroinflammation. |
| Q33422836 | Neutralizations of IL-17A and IL-21 regulate regulatory T cell/T-helper 17 imbalance via T-helper 17-associated signaling pathway in immune thrombocytopenia |
| Q37001149 | New complexities in helper T cell fate determination and the implications for autoimmune diseases |
| Q38799600 | New insights into the role of T cells in pathogenesis of psoriasis and psoriatic arthritis |
| Q37846678 | New interleukin-23 pathway inhibitors in dermatology: ustekinumab, briakinumab, and secukinumab |
| Q37556159 | Noncanonical K27-linked polyubiquitination of TIEG1 regulates Foxp3 expression and tumor growth. |
| Q54966462 | Norepinephrine Inhibits Th17 Cells via β2-Adrenergic Receptor (β2-AR) Signaling in a Mouse Model of Rheumatoid Arthritis. |
| Q37330081 | Norepinephrine and adenosine-5'-triphosphate synergize in inducing IL-6 production by human dermal microvascular endothelial cells |
| Q47764326 | Novel genetic risk markers for ulcerative colitis in the IL2/IL21 region are in epistasis with IL23R and suggest a common genetic background for ulcerative colitis and celiac disease |
| Q46089932 | Novel therapeutic targets along the Th17 pathway |
| Q43296795 | Obesity predisposes to Th17 bias |
| Q53068101 | Oestrogen up-regulates interleukin-21 production by CD4(+) T lymphocytes in patients with systemic lupus erythematosus. |
| Q37635735 | Of mice and men: how animal models advance our understanding of T-cell function in RA. |
| Q34027620 | Only one independent genetic association with rheumatoid arthritis within the KIAA1109-TENR-IL2-IL21 locus in Caucasian sample sets: confirmation of association of rs6822844 with rheumatoid arthritis at a genome-wide level of significance |
| Q45899456 | Optimization of human Th17 cell differentiation in vitro: evaluating different polarizing factors. |
| Q50959906 | Pathogen-induced human TH17 cells produce IFN-γ or IL-10 and are regulated by IL-1β. |
| Q39434888 | Pathogenic Role of IL-17-Producing Immune Cells in Obesity, and Related Inflammatory Diseases |
| Q37419035 | Pathophysiology of multiple sclerosis |
| Q36395586 | Paucity of IL-21-producing CD4(+) T cells is associated with Th17 cell depletion in SIV infection of rhesus macaques |
| Q35915482 | Pentraxin 3(PTX 3): an endogenous modulator of the inflammatory response |
| Q84233203 | Periductal interleukin-17 production in association with biliary innate immunity contributes to the pathogenesis of cholangiopathy in primary biliary cirrhosis |
| Q34983123 | Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments |
| Q36346324 | Phenotypes of Peripheral Blood Lymphocytes and Cytokine Expression in Polymyositis and Dermatomyositis before Treatment and after Clinical Remission |
| Q38310232 | Plasticity of human CD4 T cell subsets |
| Q34376236 | Positive and Negative Regulation of Th17 Cell Differentiation: Evaluating The Impact of RORC2. |
| Q54355713 | Possible involvement of IL-21 and IL-10 on salivary IgA levels in chronic periodontitis subjects. |
| Q48312123 | Possible involvement of chemokine C-C receptor 7- programmed cell death-1+ follicular helper T-cell subset in the pathogenesis of autoimmune hepatitis. |
| Q34424965 | Potentiation of Th17 cytokines in aging process contributes to the development of colitis |
| Q92075986 | Presence, function, and regulation of IL-17F-expressing human CD4+ T cells |
| Q33986006 | Primary B-cell deficiencies reveal a link between human IL-17-producing CD4 T-cell homeostasis and B-cell differentiation |
| Q35633994 | Priming microenvironments dictate cytokine requirements for T helper 17 cell lineage commitment. |
| Q45939390 | Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells. |
| Q46041262 | Prostaglandin E2 enhances Th17 responses via modulation of IL-17 and IFN-gamma production by memory CD4+ T cells |
| Q92434479 | Psoriasis: Association of interleukin-17 gene polymorphisms with severity and response to treatment |
| Q27026785 | Putting together the psoriasis puzzle: an update on developing targeted therapies |
| Q36847004 | RORC2 Genetic Variants and Serum Levels in Patients with Rheumatoid Arthritis |
| Q36610596 | RORC2 gene silencing in human Th17 cells by siRNA: design and evaluation of highly efficient siRNA. |
| Q45981618 | RORC2: the master of human Th17 cell programming. |
| Q34831560 | RORγt-specific transcriptional interactomic inhibition suppresses autoimmunity associated with TH17 cells |
| Q37164554 | Rapid myeloid cell transcriptional and proteomic responses to periodontopathogenic Porphyromonas gingivalis |
| Q24626339 | Recent advances in understanding the molecular mechanisms of the development and function of Th17 cells |
| Q37864851 | Recovery of the immune balance between Th17 and regulatory T cells as a treatment for systemic lupus erythematosus |
| Q36106307 | Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management |
| Q33608731 | Regulating human Th17 cells via differential expression of IL-1 receptor |
| Q35154002 | Regulation and function of IL-17A- and IL-22-producing γδ T cells. |
| Q37348457 | Regulation and function of proinflammatory TH17 cells |
| Q26799975 | Regulation of IL-17 in autoimmune diseases by transcriptional factors and microRNAs |
| Q37915047 | Regulation of Th17 cell differentiation by intestinal commensal bacteria |
| Q34953484 | Regulation of human Th9 differentiation by type I interferons and IL-21 |
| Q26830939 | Regulation of human helper T cell subset differentiation by cytokines |
| Q37374938 | Regulation of interleukin-12/interleukin-23 production and the T-helper 17 response in humans |
| Q37062815 | Regulation of pathogenic Th17 cell differentiation by IL-10 in the development of glomerulonephritis |
| Q39097028 | Regulation of the Immune Response by TGF-β: From Conception to Autoimmunity and Infection |
| Q37900645 | Regulatory T cells and IL-17-producing cells in graft-versus-host disease |
| Q36278700 | Regulatory T cells and Th17 cells in viral infections: implications for multiple sclerosis and myocarditis |
| Q37338455 | Regulatory T cells and their role in rheumatic diseases: a potential target for novel therapeutic development |
| Q37607071 | Regulatory T cells as therapeutic targets in rheumatoid arthritis |
| Q37468253 | Regulatory T cells modulate Th17 responses in patients with positive tuberculin skin test results |
| Q37021703 | Regulatory T cells vs Th17: differentiation of Th17 versus Treg, are the mutually exclusive? |
| Q35111378 | Relationship of CD146 expression to secretion of interleukin (IL)-17, IL-22 and interferon-γ by CD4(+) T cells in patients with inflammatory arthritis |
| Q40129656 | Report on the 1st scientific meeting of the "Verein zur Förderung des Wissenschaftlichen Nachwuchses in der Neurologie" (NEUROWIND e.V.) held in Mittenwalde/Motzen, Germany, Oct. 30th - Nov. 1st, 2009. |
| Q34976906 | Retinoid-related orphan receptors (RORs): critical roles in development, immunity, circadian rhythm, and cellular metabolism |
| Q37315484 | Rheumatoid arthritis: a view of the current genetic landscape |
| Q40109555 | Role of CD4 T cell helper subsets in immune response and deviation of CD8 T cells in mice |
| Q36795816 | Role of TH-17 cells in rheumatic and other autoimmune diseases |
| Q26860784 | Role of TH17 cytokines in the control of colorectal cancer |
| Q38237647 | Role of Th17 Cells in the Pathogenesis of Human IBD. |
| Q37622866 | Role of Th17 cells and IL-17 in lung transplant rejection |
| Q35767856 | Role of endometrial immune cells in implantation |
| Q51690338 | Role of podoplanin in the high interleukin-17A secretion resulting from interactions between activated lymphocytes and psoriatic skin-derived mesenchymal cells. |
| Q43279110 | Selected commensal-related bacteria and Toll-like receptor 3 agonist combinatorial codes synergistically induce interleukin-12 production by dendritic cells to trigger a T helper type 1 polarizing programme. |
| Q44237691 | Serum IL-17 and IL-23 levels and autoantigen-specific Th17 cells are elevated in patients with ANCA-associated vasculitis |
| Q57594184 | Short-Chain Fatty Acids Regulate Cytokines and Th17/Treg Cells in Human Peripheral Blood Mononuclear Cellsin vitro |
| Q37367853 | Signal transduction and Th17 cell differentiation |
| Q35238480 | Signal transduction pathways and transcriptional regulation in Th17 cell differentiation |
| Q34986405 | Signalling through C-type lectin receptors: shaping immune responses |
| Q58326709 | Simvastatin inhibits secretion of Th17-polarizing cytokines and antigen presentation by DCs in patients with relapsing remitting multiple sclerosis |
| Q90781384 | Single-cell transcriptomics of human T cells reveals tissue and activation signatures in health and disease |
| Q34331407 | Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells |
| Q35193745 | Stability of human rapamycin-expanded CD4+CD25+ T regulatory cells |
| Q37851349 | State of the union between metabolism and the immune system in type 2 diabetes. |
| Q27670714 | Structural Basis of Digoxin That Antagonizes ROR t Receptor Activity and Suppresses Th17 Cell Differentiation and Interleukin (IL)-17 Production |
| Q37164125 | Surveillance of antigen-presenting cells by CD4+ CD25+ regulatory T cells in autoimmunity: immunopathogenesis and therapeutic implications. |
| Q37316528 | Systemic and local interleukin-17 and linked cytokines associated with Sjögren's syndrome immunopathogenesis |
| Q26823613 | T Cells: Soldiers and Spies--The Surveillance and Control of Effector T Cells by Regulatory T Cells |
| Q92634783 | T Helper 9 Cells: A New Player in Immune-Related Diseases |
| Q89860707 | T Helper Cells: The Modulators of Inflammation in Multiple Sclerosis |
| Q28081582 | T Helper Lymphocyte Subsets and Plasticity in Autoimmunity and Cancer: An Overview |
| Q41881121 | T cell unresponsiveness in a pediatric cystic fibrosis patient: a case report |
| Q37777431 | T cells in multiple sclerosis and experimental autoimmune encephalomyelitis. |
| Q38079816 | T cells out of control--impaired immune regulation in the inflamed joint |
| Q36973651 | T cell–derived inducible nitric oxide synthase switches off Th17 cell differentiation |
| Q34702070 | T follicular helper cells mediate expansion of regulatory B cells via IL-21 in Lupus-prone MRL/lpr mice |
| Q24609737 | T helper 17 cell heterogeneity and pathogenicity in autoimmune disease |
| Q38162223 | T helper 17 cells in autoimmune liver diseases |
| Q37669790 | T helper 17 cells: discovery, function, and physiological trigger |
| Q34939023 | T helper cytokine patterns: defined subsets, random expression, and external modulation |
| Q34180508 | T regulatory cells control antigen-induced recruitment of mast cell progenitors to the lungs of C57BL/6 mice |
| Q35623903 | T(H)17 cells in tumour immunity and immunotherapy. |
| Q34691040 | T-cell growth, cell surface organization, and the galectin-glycoprotein lattice |
| Q35220895 | TAM receptor knockout mice are susceptible to retinal autoimmune induction |
| Q37316137 | TGF-beta can leave you breathless |
| Q64900222 | TGF-beta indirectly favors the development of human Th17 cells by inhibiting Th1 cells. |
| Q34113303 | TGF-beta induces IL-9 production from human Th17 cells. |
| Q37528532 | TGF-β Affects the Differentiation of Human GM-CSF+ CD4+ T Cells in an Activation- and Sodium-Dependent Manner |
| Q39094862 | TGF-β regulation of encephalitogenic and regulatory T cells in multiple sclerosis |
| Q28275410 | TGFβ signalling in context |
| Q36955309 | TH-17 cells in rheumatoid arthritis |
| Q38016854 | TH17 Cells in Autoimmunity and Immunodeficiency: Protective or Pathogenic? |
| Q37467739 | TH17 cells and regulatory T cells in primary immunodeficiency diseases |
| Q38007258 | TH17 deficiency in human disease |
| Q34997144 | TIM-3 is expressed on activated human CD4+ T cells and regulates Th1 and Th17 cytokines |
| Q27026324 | Targeting of interleukin-17 in the treatment of psoriasis |
| Q33894387 | Th 17 cells interplay with Foxp3+ Tregs in regulation of inflammation and autoimmunity |
| Q51961643 | Th memory for interleukin-17 expression is stable in vivo. |
| Q83011878 | Th-17 associated cytokines in patients with reactive arthritis/undifferentiated spondyloarthropathy |
| Q64092917 | Th17 and Th1 Lymphocytes in Oligoarticular Juvenile Idiopathic Arthritis |
| Q37989545 | Th17 and regulatory T cells in women with recurrent pregnancy loss |
| Q34395054 | Th17 and regulatory T cells: implications for AIDS pathogenesis |
| Q87056606 | Th17 cell expansion in gastric cancer may contribute to cancer development and metastasis |
| Q37845414 | Th17 cell, the new player of neuroinflammatory process in multiple sclerosis. |
| Q84983013 | Th17 cells and human arthritic diseases |
| Q35051685 | Th17 cells and interleukin-17 increase with poor prognosis in patients with acute myeloid leukemia |
| Q33838915 | Th17 cells and regulatory T cells in elite control over HIV and SIV. |
| Q21284677 | Th17 cells in autoimmune and infectious diseases |
| Q38181087 | Th17 cells in immunity and autoimmunity. |
| Q37173921 | Th17 cells: from precursors to players in inflammation and infection |
| Q36698010 | Th17 cytokines induce pro-fibrotic cytokines release from human eosinophils |
| Q26775934 | Th17 plasticity and its changes associated with inflammatory bowel disease |
| Q90661480 | Th17 reprogramming of T cells in systemic juvenile idiopathic arthritis |
| Q40110959 | Th17 response and inflammatory autoimmune diseases |
| Q37456949 | Th17-associated cytokines as a therapeutic target for steroid-insensitive asthma |
| Q27023029 | Th22 cells in allergic disease |
| Q37989164 | The IL-23/IL-17 pathway in inflammatory bowel disease |
| Q34969188 | The IL-23/Th17 axis in the immunopathogenesis of psoriasis |
| Q50175862 | The Interleukin (IL)-23/T helper (Th)17 Axis in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis. |
| Q37393703 | The T(reg)/Th17 cell balance: a new paradigm for autoimmunity |
| Q47141013 | The Th17 Lineage: From Barrier Surfaces Homeostasis to Autoimmunity, Cancer, and HIV-1 Pathogenesis |
| Q36713721 | The Th17 family: flexibility follows function. |
| Q38101877 | The Th17 pathway as a therapeutic target in rheumatoid arthritis and other autoimmune and inflammatory disorders. |
| Q50949116 | The Wnt inhibitor secreted Frizzled-Related Protein 1 (sFRP1) promotes human Th17 differentiation. |
| Q34532223 | The adjuvant double mutant Escherichia coli heat labile toxin enhances IL-17A production in human T cells specific for bacterial vaccine antigens |
| Q37516563 | The biological and clinical importance of the 'new generation' cytokines in rheumatic diseases |
| Q64235398 | The change of Th17/Treg cells and IL-10/IL-17 in Chinese children with Henoch-Schonlein purpura: A PRISMA-compliant meta-analysis |
| Q31096343 | The changes of Th17 cells and the related cytokines in the progression of human colorectal cancers |
| Q37728840 | The cytokine milieu in the interplay of pathogenic Th1/Th17 cells and regulatory T cells in autoimmune disease |
| Q61840854 | The deregulation of regulatory T cells on interleukin-17-producing T helper cells in patients with unexplained early recurrent miscarriage |
| Q56607716 | The dual nature of TH17 cells: shifting the focus to function |
| Q35294513 | The dysregulation of cytokine networks in systemic lupus erythematosus |
| Q36959641 | The effect of diabetes-associated autoantigens on cell processes in human PBMCs and their relevance to autoimmune diabetes development |
| Q37290719 | The effects of IL-6 on CD4 T cell responses |
| Q47157832 | The effects of freeze-dried Ganoderma lucidum mycelia on a recurrent oral ulceration rat model. |
| Q24623195 | The emerging role of IL-17 in the pathogenesis of psoriasis: preclinical and clinical findings |
| Q38618889 | The emerging role of aryl hydrocarbon receptor in the activation and differentiation of Th17 cells. |
| Q21131158 | The environment of regulatory T cell biology: cytokines, metabolites, and the microbiome |
| Q37682484 | The immunology of fibrosis: innate and adaptive responses |
| Q38164343 | The immunomodulatory effect of probiotics beyond atopy: an update |
| Q44074186 | The inducible costimulator (ICOS) is critical for the development of human T(H)17 cells. |
| Q41551980 | The inducible costimulator augments Tc17 cell responses to self and tumor tissue. |
| Q33808773 | The loss of CCR6+ and CD161+ CD4+ T-cell homeostasis contributes to disease progression in SIV-infected rhesus macaques |
| Q35596984 | The many faces of Th17 cells |
| Q35591962 | The microbiome in infectious disease and inflammation |
| Q38181085 | The multifaceted role of Th17 lymphocytes and their associated cytokines in cancer |
| Q37377446 | The nuclear receptor PPAR gamma selectively inhibits Th17 differentiation in a T cell-intrinsic fashion and suppresses CNS autoimmunity |
| Q38984914 | The obesity-related pathology and Th17 cells. |
| Q27005951 | The outliers become a stampede as immunometabolism reaches a tipping point |
| Q33354622 | The periprosthetic capsule and connective tissue diseases: a piece in the puzzle of autoimmune/autoinflammatory syndrome induced by adjuvants |
| Q37280352 | The phenotype of human Th17 cells and their precursors, the cytokines that mediate their differentiation and the role of Th17 cells in inflammation. |
| Q37528094 | The plasticity of human Treg and Th17 cells and its role in autoimmunity |
| Q37902959 | The potential role of interleukin-17 in severe asthma |
| Q45835190 | The prevalence of Th17 cells and FOXP3 regulate T cells (Treg) in children with primary nephrotic syndrome |
| Q34196541 | The regulatory effect of liuwei dihuang pills on cytokines in mice with experimental autoimmune encephalomyelitis |
| Q24648939 | The role of NKT cells in tumor immunity |
| Q37598359 | The role of T helper type 17 cells in inflammatory arthritis |
| Q48179424 | The role of T-helper 17 (Th17) cells in patients with medulloblastoma |
| Q52570914 | The role of TGF-β in Th17 differentiation. |
| Q38565395 | The role of Th17 and Treg responses in the pathogenesis of RSV infection. |
| Q37831821 | The role of Th17 lymphocytes in the autoimmune and chronic inflammatory diseases |
| Q37812002 | The role of cytokines in Guillain-Barré syndrome |
| Q38238738 | The role of interleukin 17 in tumour proliferation, angiogenesis, and metastasis. |
| Q36085086 | The role of nuclear receptors in regulation of Th17/Treg biology and its implications for diseases |
| Q46007942 | The role of retinoic acid-related orphan receptor variant 2 and IL-17 in the development and function of human CD4+ T cells. |
| Q38473746 | The skewed balance between Tregs and Th17 in chronic lymphocytic leukemia. |
| Q28118511 | The ubiquitin ligase Stub1 negatively modulates regulatory T cell suppressive activity by promoting degradation of the transcription factor Foxp3 |
| Q39015080 | Therapeutic Potential of Targeting the Th17/Treg Axis in Autoimmune Disorders. |
| Q36490256 | Therapeutic targeting of the inflammome |
| Q51018464 | Tobacco smoke is related to Th17 generation with clinical implications for psoriasis patients. |
| Q24616336 | Transcription factor IRF8 directs a silencing programme for TH17 cell differentiation |
| Q38123463 | Transcription factor interplay in T helper cell differentiation |
| Q37425866 | Transcriptional regulatory networks in Th17 cell differentiation |
| Q44117426 | Transforming growth factor (TGF)-β signalling is increased in rheumatoid synovium but TGF-β blockade does not modify experimental arthritis |
| Q37402405 | Transforming growth factor beta is dispensable for the molecular orchestration of Th17 cell differentiation |
| Q37632472 | Translational mini-review series on Th17 cells: CD4 T helper cells: functional plasticity and differential sensitivity to regulatory T cell-mediated regulation |
| Q37632469 | Translational mini-review series on Th17 cells: development of mouse and human T helper 17 cells. |
| Q35012792 | Translational mini-review series on Th17 cells: function and regulation of human T helper 17 cells in health and disease. |
| Q36974002 | Tregs are regulated by cytokines: implications for autoimmunity |
| Q36057492 | Trial Watch: Immunostimulatory cytokines |
| Q30882988 | Tumor-like stem cells derived from human keloid are governed by the inflammatory niche driven by IL-17/IL-6 axis |
| Q37478061 | Type 17 T helper cells-origins, features and possible roles in rheumatic disease |
| Q41863506 | Upregulated IL-21 and IL-21 receptor expression is involved in experimental autoimmune uveitis (EAU). |
| Q24596756 | Ustekinumab in psoriasis immunopathology with emphasis on the Th17-IL23 axis: a primer |
| Q27009990 | Utilizing regulatory T cells against rheumatoid arthritis |
| Q50653450 | Vitamin D improves cognitive function and modulates Th17/T reg cell balance after hepatectomy in mice. |
| Q35604631 | cAMP-responsive element modulator (CREM)α protein induces interleukin 17A expression and mediates epigenetic alterations at the interleukin-17A gene locus in patients with systemic lupus erythematosus |
| Q34378756 | gp130 at the nexus of inflammation, autoimmunity, and cancer |
| Q40326814 | miR-27a and miR-214 exert opposite regulatory roles in Th17 differentiation via mediating different signaling pathways in peripheral blood CD4+ T lymphocytes of patients with relapsing-remitting multiple sclerosis. |
Search more.